155 related articles for article (PubMed ID: 9260894)
1. Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein.
Lee Y; Chen Y; Chang LS; Johnson LF
Exp Cell Res; 1997 Aug; 234(2):270-6. PubMed ID: 9260894
[TBL] [Abstract][Full Text] [Related]
2. Introduction of an initiator element in the mouse thymidylate synthase promoter alters S phase regulation but has no effect on promoter bidirectionality.
Kapadia F; Johnson LF
J Cell Biochem; 2006 Feb; 97(3):599-608. PubMed ID: 16215980
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control elements of the rat thymidylate synthase promoter: evolutionary conservation of regulatory features.
Lee Y; Johnson LF
Exp Cell Res; 2000 Jul; 258(1):53-64. PubMed ID: 10912787
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activation of the TATA-less mouse thymidylate synthase promoter by the Ets transcription factor GABP and Sp1.
Rudge TL; Johnson LF
Exp Cell Res; 2002 Mar; 274(1):45-55. PubMed ID: 11855856
[TBL] [Abstract][Full Text] [Related]
5. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
6. Pre-mRNA processing enhancer (PPE) element increases the expression of an intronless thymidylate synthase gene but does not affect intron-dependent S phase regulation.
Lee TX; Johnson LF
J Cell Biochem; 1998 May; 69(2):104-16. PubMed ID: 9548559
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
8. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
9. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
10. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
[TBL] [Abstract][Full Text] [Related]
11. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
Pietrzak M; Puzianowska-Kuznicka M
Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
[TBL] [Abstract][Full Text] [Related]
12. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
14. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
15. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Thomas S; Reisman D
Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
[TBL] [Abstract][Full Text] [Related]
16. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
Mukhopadhyay T; Roth JA
Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
[TBL] [Abstract][Full Text] [Related]
17. Complex transcriptional initiation pattern of the thymidylate synthase promoter in mouse tissues.
Lee Y; Shen G; Johnson LF
Arch Biochem Biophys; 1999 Dec; 372(2):389-92. PubMed ID: 10600180
[TBL] [Abstract][Full Text] [Related]
18. Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.
Yu L; Ugai S; O-Wang J; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M
Oncol Rep; 2003; 10(5):1301-5. PubMed ID: 12883697
[TBL] [Abstract][Full Text] [Related]
19. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
Moberg KH; Tyndall WA; Hall DJ
J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
Willis A; Jung EJ; Wakefield T; Chen X
Oncogene; 2004 Mar; 23(13):2330-8. PubMed ID: 14743206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
